Mangoceuticals, Inc. (MGRX) income statement
MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$0.15−0.01 (-8.44%)
Close on Nov 18, 2026Market cap $3.16MP/E –Yield –
Mangoceuticals, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 54.4%
- Operating margin
- -3829.0%
- Net margin
- -4791.3%
- Return on equity, FY2025
- -141.6%
Financial strength
- Current ratio
- 0.18
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 16.4%
Valuation
- P/E ratio
- –
- Price to sales
- 10.02
- Price to book
- 0.25
- Dividend yield
- –
See a number that looks wrong?